Investing Profile
Klaus Breiner
Your Intro Paths to Klaus Breiner
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Klaus is a member of
University of North Carolina at Chapel Hill Network
20 CONNECTIONS
Booz Allen Hamilton Network
17 CONNECTIONS
Find Klaus Breiner on
cbCurrent Investing Position
Pureos Bioventures Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Current Fund Size
$205M
Klaus Breiner is on these Sector & Stage Rankings
Klaus Breiner's Experience
Co-Founder & Vice-Chairman (Executive Chairman till mid-2016) Vaximm AG2008 - 2022
Board Director ORTHOCON2006 - 2021
Senior Adviser Private Equity Bellevue2004 - 2021
Board Director Alpex Pharma SA2007 - 2020
Board Director AM-Pharma2011 - 2019
Board Director Pevion Biotech AG2007 - 2011
Board Director Glycart Biotechnology AG2003 - 2004
Investment Manager Global Life Science Ventures2001 - 2004
Associate Booz Allen Hamilton2000 - 2001
Post-doctoral Fellow ETH Zurich1999 - 2000
Post-doctoral Fellow ZMBH - Universität Heidelberg1998 - 1999
Research Associate ZMBH - Universität Heidelberg1995 - 1998
Co-founder and Managing Director Pureos Partners AG2021 - Present
Non-executive Director VICO Therapeutics B.V.2021 - Present
Managing Partner Pureos Bioventures2017 - Present
Partner BB Biotech Ventures2004 - Present
Klaus Breiner's Education
Ruprecht-Karls-Universität Heidelberg / University of Heidelberg Ph.D. (Dr.rer.nat.) Biochemistry and Molecular Biology
University of North Carolina at Chapel Hill Master of Arts (M.A.) Chemistry
Heinrich-Heine-Universität Düsseldorf Chemistry
Fernuniversität Hagen Business Administration & Economics
Fachhochschule Aachen Diplom Ingenieur Chemical Engineering
Investors who invest with Klaus Breiner
Founders who looked at Klaus Breiner's profile also looked at these Scouts & Angels